Age: 28.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Injection site erythema, Injection site swelling, Rash, Rash erythematous
Clinical narrative: Rash/rash did have a pretty discreet or distinct area around the injection site; She says it was pretty red and you could tell the area was swollen at first, and it has faded; She says it was pretty red and you could tell the area was swollen at first, and it has faded; She says that the rash this morning has spread to her left chest wall and breast area, and she was looking at her body in other places and saw the reaction was on the rest of her body too/rash had maybe a little mild itch; injection site may bleed longer which was the only thing notable; This is a spontaneous report from a contactable physician (patient). A 28-year-old female patient received single dose of BNT162B2 (lot number: EK5730, exp date not reported), via an unspecified route of administration (one injection to left deltoid) on 18Dec2020 07:00 for primary prevention. Medical history included rare bleeding disorder from 2016, and seasonal allergies. She says she had no effects from it but knows of it from genetic testing. Patient did not receive any other vaccines at the same time as this one, or any other medications. Patient was a resident doctor at the hospital and was calling as consumer. She received her first dose of the Pfizer BioNTech COVID-19 vaccine on 18Dec2020 (Friday morning at 07:00AM). She had gotten sort of a whole body generalized rash which the morning of reporting was worse nearer the site and left chest wall area. She says she would like to see if this has happened to and been reported by others. The vaccine was offered by her employer to any staff who wanted to get it, and she was in phase one. She says that there wasn't a specific provider who prescribed it. She has the card that they gave her following the injection and says that it doesn't have an expiration date on it, just the date given and the name of the clinic site. She says it just says Pfizer on this part, on the card. She says on the other form it says Pfizer BioNTech COVID-19 vaccine. She says that there was no dose information provided for the injection. Patient further reported that the rash did have a pretty discreet or distinct area around the injection site up through probably the day before reporting (onset date: Dec2020). It was pretty red, and you could tell the area was swollen at first, and it has faded. She says that the rash the morning of reporting had spread to her left chest wall and breast area, and she was looking at her body in other places and saw the reaction was on the rest of her body too. She says that the rash had maybe a little mild itch, she hadn't noticed if there was anything, just a mild itch, not significant. She didn't do any treatment for the rash specifically, she did take loratadine (CLARITIN) the morning of reporting, but not for that reason, as it was for seasonal allergies, not because of the rash. She provides potential LOT 9HE36498, and says there was no UPC, she got the loratadine and it could have been in original package as one of two, there was no bar code on the label. She provides a second potential LOT 61282ZYF3, and EXP May2021. She says she was told the injection site may bleed longer, due to rare bleeding disorder, which was the only thing notable. No investigation assessment performed. The patient recovered from site swollen on Dec2020. The outcome of other events was unknown.